Annual Working Capital
$7.10 M
+$8.35 M+669.85%
December 31, 2023
Summary
- As of February 21, 2025, GDTC annual working capital is $7.10 million, with the most recent change of +$8.35 million (+669.85%) on December 31, 2023.
- During the last 3 years, GDTC annual working capital has risen by +$8.05 million (+848.00%).
- GDTC annual working capital is now at all-time high.
Performance
GDTC Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$5.42 M
-$1.69 M-23.73%
June 30, 2024
Summary
- As of February 21, 2025, GDTC quarterly working capital is $5.42 million, with the most recent change of -$1.69 million (-23.73%) on June 30, 2024.
- Over the past year, GDTC quarterly working capital has stayed the same.
- GDTC quarterly working capital is now -34.14% below its all-time high of $8.22 million, reached on June 30, 2023.
Performance
GDTC Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
GDTC Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +669.9% | 0.0% |
| 3 y3 years | +848.0% | 0.0% |
| 5 y5 years | +848.0% | 0.0% |
GDTC Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +669.9% | -34.1% | +534.6% |
| 5 y | 5-year | at high | +669.9% | -34.1% | +534.6% |
| alltime | all time | at high | +669.9% | -34.1% | +534.6% |
CytoMed Therapeutics Limited Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $5.42 M(-23.7%) |
| Dec 2023 | $7.10 M(-669.9%) | $7.10 M(-13.7%) |
| Jun 2023 | - | $8.22 M(-759.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -$1.25 M(-588.1%) | -$1.25 M(+98.3%) |
| Jun 2022 | - | -$628.50 K(-346.2%) |
| Dec 2021 | $255.30 K(-126.9%) | $255.30 K |
| Dec 2020 | -$949.40 K | - |
FAQ
- What is CytoMed Therapeutics Limited annual working capital?
- What is the all time high annual working capital for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual working capital year-on-year change?
- What is CytoMed Therapeutics Limited quarterly working capital?
- What is the all time high quarterly working capital for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited quarterly working capital year-on-year change?
What is CytoMed Therapeutics Limited annual working capital?
The current annual working capital of GDTC is $7.10 M
What is the all time high annual working capital for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual working capital is $7.10 M
What is CytoMed Therapeutics Limited annual working capital year-on-year change?
Over the past year, GDTC annual working capital has changed by +$8.35 M (+669.85%)
What is CytoMed Therapeutics Limited quarterly working capital?
The current quarterly working capital of GDTC is $5.42 M
What is the all time high quarterly working capital for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high quarterly working capital is $8.22 M
What is CytoMed Therapeutics Limited quarterly working capital year-on-year change?
Over the past year, GDTC quarterly working capital has changed by $0.00 (0.00%)